Accelleron Industries (ACLN) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
16 Oct, 2026Executive summary
FY23 delivered strong standalone performance: revenue grew 17.2% and operational EBITA reached $223m, exceeding guidance after H1.
Separation from ABB was completed in July; build-up progressed on time and within budget.
Financial highlights
Revenue was $915m versus $781m in 2022, up 17.2%; organic growth was 15.5%, with 3 ppts from OMT.
Operational EBITA rose to $223m from $192m; margin was 24.4% versus 24.6%, despite standalone costs.
Income from operations was $141m after $82m of one-off and non-operational expenses; net income was $110m versus $130m.
Free cash flow was $109m and conversion was 99%, versus $99m and 77% in 2022; H2 conversion exceeded 150%.
Outlook and guidance
FY24 guidance, assuming a normalized business environment: total revenue growth of 4–6% and operational EBITA margin of around 24.5%.
FY24 free cash flow conversion, net leverage and dividend policy expected in line with mid-term guidance.
Mid-term guidance: organic revenue growth of 2–4%, operational EBITA margin of 23–26%, free cash flow conversion of 90–100%, net leverage of 0.5–1.5x and stable-to-growing dividends.
2024 priorities include gaining turbocharger share, expanding Tekomar XPERT, increasing OMT capacity and completing build-up with up to $20m of non-operational costs.
Latest events from Accelleron Industries
- Revenue up 21.3% and net income up 31.5%, with 2026 growth guidance raised to 14–17%.ACLN
H1 2026 - Record revenue and profit growth, robust outlook, and higher shareholder returns in 2025.ACLN
H2 2025 - H1 2025 revenue up 20.3%, net income up 29.5%, but US tariffs to pressure margins.ACLN
H1 2025 - Raised 2025 revenue guidance follows 20.1% H1 growth and robust marine and energy demand.ACLN
H1 2025 TU - Revenue up 14.5%, net income up 89%, margin at 25.4%, with strategic acquisitions.ACLN
H1 2024 - Record revenue, profit, and dividend growth, with strong 2025 outlook and robust market demand.ACLN
H2 2024